1-3 of 3
Ivo Palasek
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Monitoring of Minimal Residual Disease in NPM1 Mutated Acute Myeloid Leukemia (AML) – a Single Center Experience in 27 Patients.

Dana Dvorakova, Zdenek Racil, Ivo Palasek, Marketa Protivankova, Ivana Jeziskova, Martina Lengerova, Jiri Mayer
Journal: Blood
Blood (2009) 114 (22): 4672.
https://doi.org/10.1182/blood.V114.22.4672.4672
Published: 2009
Journal Articles

Detection and Treatment of Molecular Relapse in Acute Myeloid Leukemia with RUNX1, CBFB or MLL Gene Translocations. Frequent Quantitative Monitoring of Molecular Markers in Different Compartments and Correlation with WT1 Gene Expression.

Michael Doubek, MD, PhD, Ivo Palasek, MD, Zdenek Pospisil, PhD, Sona Struncova, PhD, Dana Dvorakova, PhD, Marek Borsky, PhD, Martin Klabusay, PhD, Yvona Brychtova, MD, Marta Krejci, MD, PhD, Jiri Mayer, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 4356.
https://doi.org/10.1182/blood.V110.11.4356.4356
Published: 2007
Journal Articles

Detection of Molecular Relapse of AML by Very Frequent Quantitative Monitoring of Different Molecular Markers (Fusion Transcripts and WT1) in Different Compartments (Peripheral Blood-PB, Bone Marrow-BM, and Selected CD34+ Bone Marrow Cells) and Its Treatment with Chemotherapy or Gemtuzumab Ozogamicin.

Jiri Mayer, Ivo Palasek, Zdenek Pospisil, Sona Struncova, Dana Dvorakova, Marek Borsky, Martin Klabusay, Michael Doubek, Yvona Brychtova, Zdenek Racil
Journal: Blood
Blood (2006) 108 (11): 4481.
https://doi.org/10.1182/blood.V108.11.4481.4481
Published: 2006